66 participants
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-25
- Start Date:
- 2024-12-16
- Completion:
- 2026-03-31
Conditions
- Chronic Rhinosinusitis Without Nasal Polyps
Interventions
- DRUG
No Results Yet